Cargando…
Identification of a new potential plasmatic biomarker panel for the diagnosis of malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare, highly aggressive tumor strongly associated with asbestos exposure and characterized by poor prognosis. Currently, diagnosis is based on invasive techniques; thus, there is a need to identify non-invasive biomarkers to detect the disease. I...
Autores principales: | Ferrari, Luca, Iodice, Simona, Cantone, Laura, Dallari, Barbara, Dioni, Laura, Bordini, Lorenzo, Palleschi, Alessandro, Mensi, Carolina, Pesatori, Angela Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885 srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766837/ https://www.ncbi.nlm.nih.gov/pubmed/36475505 http://dx.doi.org/10.23749/mdl.v113i6.13522 |
Ejemplares similares
-
Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease
por: Cavalleri, Tommaso, et al.
Publicado: (2017) -
Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
por: Ferrari, Luca, et al.
Publicado: (2020) -
Pleural mesothelioma in a circus worker
por: Mensi, Carolina, et al.
Publicado: (2021) -
Asbestos Exposure in Patients with Malignant Pleural Mesothelioma included in the PRIMATE Study, Lombardy, Italy
por: Spinazzè, Andrea, et al.
Publicado: (2022) -
Second Primary Cancers in a Population-Based Mesothelioma Registry
por: Mensi, Carolina, et al.
Publicado: (2023)